In this presentation I've tried to summarize classification of hemolytic anemia and in depth review of rbc membrane disorders like hereditary spherocytosis, hereditary elliptocytosis, enzymopathies of hemolytic anemia like g6pd disorder, pyruvate kinase disorders, hemoglobinopathies related to hemolytic anemia like thalassemia, sickle cell anemia and especially pathophysiology and mechanism of hemolysis either extravascular or intravascular. Hope it helps you understand the entity better.
This Presentation of Hemolytic Anemia try to cover important Hemato-pathological aspects of Red cell membrane disorders ( Hereditary Spherocytosis, others ) , Enzymopathies ( G6PD deficieny, others ) and Hemoglobinopathies ( Thallasemia, SCA) and their differentiation. References includes Robbins pathology, Wintrobes atlas and text, and others
This Presentation of Hemolytic Anemia try to cover important Hemato-pathological aspects of Red cell membrane disorders ( Hereditary Spherocytosis, others ) , Enzymopathies ( G6PD deficieny, others ) and Hemoglobinopathies ( Thallasemia, SCA) and their differentiation. References includes Robbins pathology, Wintrobes atlas and text, and others
Hereditary spherocytosis is an inherited condition related to RBC destruction. its diagnosis is require to differentiate immune hemolytic anemia and G-6-P-D deficiency anemia
Hereditary spherocytosis is an inherited condition related to RBC destruction. its diagnosis is require to differentiate immune hemolytic anemia and G-6-P-D deficiency anemia
Dr. Sachin Verma is a young, diligent and dynamic physician. He did his graduation from IGMC Shimla and MD in Internal Medicine from GSVM Medical College Kanpur. Then he did his Fellowship in Intensive Care Medicine (FICM) from Apollo Hospital Delhi. He has done fellowship in infectious diseases by Infectious Disease Society of America (IDSA). He has also done FCCS course and is certified Advance Cardiac Life support (ACLS) and Basic Life Support (BLS) provider by American Heart Association. He has also done a course in Cardiology by American College of Cardiology and a course in Diabetology by International Diabetes Centre. He specializes in the management of Infections, Multiorgan Dysfunctions and Critically ill patients and has many publications and presentations in various national conferences under his belt. He is currently working in NABH Approved Ivy super-specialty Hospital Mohali as Consultant Intensivists and Physician.
Anaemias, causes, pathophysiology, morphological and aetiological types, Investigations and treatment, including blood transfusion were discussed in this presentation
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
2. ANEMIA - Anemia is defined as reduction of the total
circulating red cell mass below normal limits.
Anemia reduces the oxygen carrying capacity of
blood, leading to tissue hypoxia.
Anemia is usually diagnosed based on reduction in
hematocrit and Hemoglobin concentration of the blood to
levels that are below the normal range
Hemolytic Anemia – Increased red cell destruction (Life
span of RBC could be as low as 15 days)
3. Red cell destruction occur by 2 mechanisms-
Extravascular Hemolysis – The site of
destruction is mainly spleen and this is the major
mechanism of red cell hemolysis. Red cells are taken
up by the cells of RE system where they are
destroyed and digested
Intravascular Hemolysis– This is the minor
pathway of red cell destruction and red cells are
destroyed in circulation releasing hemoglobin.
5. Extravascular Hemolysis
Senescent red cells
Phagocytosed by RE
cells of Spleen
Hemoglobin released
in RE cells and broken
down
Heme + Globin
Heme breaks down into
iron + protoporphyrin
Globin broken down to
amino acids
6. Extravascular Hemolysis
Senescent red cells
Phagocytosed by RE
cells of Spleen
Hemoglobin released
in RE cells and broken
down
Heme + Globin
Heme breaks down into
iron + protoporphyrin
Globin broken down to
amino acids
Re-utilised for
synthesis of α, β chains
7. Extravascular Hemolysis
Senescent red cells
Phagocytosed by RE
cells of Spleen
Hemoglobin released
in RE cells and broken
down
Heme + Globin
Heme breaks down into
iron + protoporphyrin
Globin broken down to
amino acids
Re-utilised for
synthesis of α, β chains
Iron in plasma carried
as transferrin
Biliverdin
8. Extravascular Hemolysis
Senescent red cells
Phagocytosed by RE
cells of Spleen
Hemoglobin released
in RE cells and broken
down
Heme + Globin
Heme breaks down into
iron + protoporphyrin
Globin broken down to
amino acids
Re-utilised for
synthesis of α, β chains
Iron in plasma carried
as transferrin
Biliverdin
Carried to iron storage
sites like bone marrow
Iron stores
9. Extravascular Hemolysis
Senescent red cells
Phagocytosed by RE
cells of Spleen
Hemoglobin released
in RE cells and broken
down
Heme + Globin
Heme breaks down into
iron + protoporphyrin
Globin broken down to
amino acids
Re-utilised for
synthesis of α, β chains
Iron in plasma carried
as transferrin
Biliverdin
Carried to iron storage
sites like bone marrow
Iron stores
Bilirubin
(unconjegated)
Conjugated in liver by
UGT1A1
Bilirubin acted upon by
bacterial enzymes in
instestine
Urobilinogen/Stercobilinogen
11. Intravascular Hemolysis
Red cells in
circulation
Red cells lyse in
circulation
Hemoglobin in
Plasma
Hemoglobinemia
Hb in urine
Combines with
Haptoglobin
12. Intravascular Hemolysis
Red cells in
circulation
Red cells lyse in
circulation
Hemoglobin in
Plasma
Hemoglobinemia
Hb in urine
Combines with
Haptoglobin
Hb absorbed by
kidney tubular cells
Hb converted to
hemosiderin in
tubular cells in few
days
Tubular cells shed
off
Hemosiderinuria
Detected in Urinary deposit by Perl’s
stain
13. Intravascular Hemolysis
Red cells in
circulation
Red cells lyse in
circulation
Hemoglobin in
Plasma
Hemoglobinemia
Hb in urine
Combines with
Haptoglobin
Hb absorbed by
kidney tubular cells
Hb converted to
hemosiderin in
tubular cells in few
days
Tubular cells shed
off
Hemosiderinuria
Detected in Urinary deposit by Pearl’s
stain
Hemoglobinuria
Positive Benzidine
tese
14. Extravascular Hemolysis Intravascular Hemolysis
Site of hemolysis R.E. Cell organs In Circulating blood
S. Methemalbumin -ve +ve
Plasma Hemoglobin -ve +ve
S. Ferritin Normal or ↑ ↓
S. Bilirubin (UC) ↑↑ ↑
S. LDH ↑ ↑↑
Urine Hemoglobin -ve +ve
Urine Hemosiderin -ve +ve
Disease states Thalassemia, Sickle cell
anemia, hereditary
spherocytosis
PNH, G-6-PD deficiency,
black water fever
Tissue iron in spleen,
liver
↑ ↓ or normal
Retic count ↑ ↑
S. Haptoglobin Normal ↓
15. Hereditory Hemolytic Anemia Acquired Hemolytic Anemia
1. Defects in red cell membranes 1. Immunohyemolytic anemia
• Hereditory Sphrecytosis • Autoimmune hemolytic anemia
• Hereditary elliptocytosis Due to warm antibodies
• Hereditary pyropoikilocytosis. o Idiopathic
• Stamatocytosis o Secondary
• Abetalipoprotenemia Due to cold antibodies
2. Defects in globin synsthesis o Cold agglutinin disease
• Thalassemias o Paroxysmal cold hemoglobinuria
• Sickling syndromes 2. Fragmentation Syndromes
• Unstable hemoglobins • Hemolytic uremic syndrome
• HbM • Thrombotic thrombocytopenic purpura
• HbD disease • Disseminated intravascular coagulation
• HbE disease • Cardiac hemolytic anemia
• HbQ India 3. Paroxysmal nocturnal hemoglobinuria
• Hemoglobin Lepore 4. Drugs and chemicals
• HbC disase • Oxidant drugs, primaquine. Dapsone
3. Enzyme deficiency of glycolytic pathway 5. Thermal Injury
• Pyruvate kinase deficiency 6. Infections
• Hexokinase deficiency • Clostridium perfringens, Welchiii
4. Enzyme deficiency of pentose phosphate pathway • Bartonellosis
• G-6-P-D deficiency • Cholera
5. Enzyme deficiency of red cell nucleotide metabolism 7. Others
16. Common findings in Hemolytic anemia
Pallor, Jaundice, splenomegaly, gall stones skeletal
abnormalities, leg ulcers, dyspnea on exertion,
tachycardia, systolic murmur
Peripheral Blood Finding
Polychromatophilia, nucleated red cells,
thrombocytosis and neutrophilia with shift to left.
Reticulocytosis
Erythroid hyperplasia in bone marrow
18. Overview
Abnormality of
protein
Disorder Comment
Ankyrin HS Common cause of
HS
β Spectrin HS, HE, HPP M/C cause of HS
Protein 4.2 HS Found in Japanese
α Spectrin HS, HE, HPP Spectrin mutation –
common cause of
HE
Band 3 HS Mushroom cells in
PBF
Protein 4.1 HE Found in Arab and
European
population
19. Hereditary Spherocytosis
Autosomal Dominant (75% cases)
Autosomal Recessive (ANK-1 & SPTB mutation)
Spectrin deficiency is the most common (Lower the spectrin content, more
severe is the hemolytic disease clinically and greater number of
spherocytes in blood)
Spectrin deficiency is associated with reduced membrane stability. These
RBC’s are exposed to shearing stresses, fagments of RBC membrane are
lost, thereby reducing cell surface to volume ratio.
RBC assume the smallest possible diameter for the volume and become
spherocytes.
Protein 4.2 (AS) and band 3 deficiency (AD) also result in spectrin
deficiency.
21. Mechanism of hemolysis in hereditary
spherocytosisSpherocytes
Reduced deformability
Greater internal viscosity
Reduced membrane
plasticity
Difficulty in passing through the inter-
endothelial fenestrations of the venous
sinusoids of spleen
22. Mechanism of hemolysis in hereditary
spherocytosisSpherocytes
Difficulty in passing through the inter-
endothelial fenestrations of the venous
sinusoids of spleen
Lactic acid
accumulates around
the cells
Red cells become conditioned,
spherical and more fragile
23. Mechanism of hemolysis in hereditary
spherocytosisSpherocytes
Difficulty in passing through the inter-
endothelial fenestrations of the venous
sinusoids of spleen
Lactic acid
accumulates around
the cells
Red cells become conditioned,
spherical and more fragile
Phagocytosed by the RE cells of
spleen
Splenomegaly
Increased extravascular hemolysis Anemia,
Reticulocytosis
24. Mechanism of hemolysis in hereditary
spherocytosisSpherocytes
Difficulty in passing through the inter-
endothelial fenestrations of the venous
sinusoids of spleen
Lactic acid
accumulates around
the cells
Red cells become conditioned,
spherical and more fragile
Phagocytosed by the RE cells of
spleen
Splenomegaly
Increased extravascular hemolysis Anemia,
Reticulocytosis
Inhibition of
glycolysis and ↓
ATP generation
Failure of sodium
pump
Accumulation of
water
Abnormal RBC
Phagocytosed by RE cells lining the
sinusoids
25. Clinical Features
May present in neonatal period, childhood or adulthood.
Anemia
Intermittent Jaundice
Splenomegaly
Gall stone
Chronic leg ulcers
Classification of severity of Hereditary Spherocytosis (HS)
Hb g/dl
Reticulocyte
Count %
Bilirubin
mg/dl
Spherocytes
on pbf
Spectrin
content % of
Normal
Osmotic
Fragility
Mild HS 11-15 3-10 1-2 Few 80-100 Normal
Moderate 8-11 7-10 1.5-2.5 + 50-80 ↑
Moderately
Severe
6-8 >10 2-3 ++ 40-70 ↑
Severe <6 >12 >3 +++ 20-50 ↑↑
26. Investigations
CBC with PBF
MCHC >36 gm/dl in neonates useful indicator
PBF – Microspherocytes, Polychromatophilia, reticulocytosis.
Bone marrow
Erythroid hyperplasia with a normoblastic marrow
Biochemical
S. Bilirubin - ↑
S. LDH - ↑
Flow cytometry based EMA binding test (Sensitive and specific)
Mean fluorescence intensity of EMA tagged RBC is lower in HS (MCF < 0.80)
Osmotic Fragility test
Shift to the curve to the right (about 25% of patients may have normal OF)
Specificity is far lower as compared to EMA
Incubated Fragility test
SDS-PAGE analysis of red cell membrane
Glycerol lysis test
Osmotic Gradient Ektacytromtery
27. Approach to a case of spherocytosis in peripheral
blood filmSpherocytes on
PBF
Reticulocyte
Counts
High Retic Count
Incubated
osmotic fragility
test
Bite cells in PBF
EMA dye binding
test, SDS-PAGE
for membrane
proteins
Unstable Hb
disease
Coombs test
Immune
mediated
hemolytic
anemia
HS, AIHA
Family History
HS
confirmed
EMA +ve
Heinz bodies +ve
on Retic preparation
G-6-PD assay for
G-6-PD deficiency
Unstable Hb
Isopropanol test
heat denaturation
test+ve
+ve -ve
+ve -ve
Coombs test
+ve
Positive
HS –ve,
AIHA
EM
A-
ve
28. AD
β- spectrin, α- spectrin structural defect or deficiency of protein 4.1lead to
changes in membrane function, elliptical shape and mild hemolysis.
Such cells should be >25% of the red cell population
Clinically
Asymptomatic
Mild hemolytic anemia
Intermittent jaundice
Three subtypes
Typical HE
Spherocytic HE
South East Asian Ovalocytosis.
AD, Seen in Malasia and Phillipines.
Oval shaped red cells with one or two transverse ridges or
longitudinal slit
Offer resistant to malaria
Hereditary Elliptocytosis
29. Rare
AR
Defective spectrin gene transmitted by one parent and also an elusive
thalassemia like defect of spectrin synthesis inherited form the normal parent.
PBF findings
Poikilocytes
Fragmented RBC
Spheroidal RBC
Elliptocytic RBC
MCHC is normal
Incubated osmotic fragility
is increased.
Hereditary Pyropoikilocytosis
30. Stoma = Fish mouth
Red cells with a central slit like pallor, Uniconcave/bowl shaped in wet smear
>30% of red cells (normal individual <5%)
Two subtype
1) Hereditary stomatocytosis (HSt)
• AD
• Deficiency of membrane protein stomatin located in the band 7 region
result in increased permeability to both Na+ and K+ increased water
content.
• Also called OVERHYDRATED stomatocytosis.
• Associated with RHAG gene mutation.
• C/F – Hemolytic anemia (mild to moderate)
• Reticulocytosis
• MCV raised (110-150 fl)
• Reduced MCHC
• Osmotic Fagility incrased
Stomatocytosis
31. 2) Xerocytosis
• AD
• Increased rate of leakage of K+ ion results in depletion of cations and water
from the red cells which become dehydrated.
• Also called as DEHYDRATED hereditary stomatocytosis. (DHSt)
• C/F – Hemolytic anemia (mild to moderate)
• Target cells, Pyknocytes and echinocytes.
• Jaundice, mild hepatosplenomegaly.
32. Red cells with 3-12 thorny projection on the cell surface due to
alteration of the lipid composition and fluidity of the red cell membrane.
Lack central pallor
Casues
Abetalipoproteinemia
Spur cell hemolytic anemia
HARP synrome
Post splenectomy
Neuroacanthocytosis
Hypothyroidism
McLeod phenotype of neonatal hepatitis.
Acanthocytosis
34. First enzyme in the hexose monophosphate pathway which protect red cells
from any oxidant injury.
Sex-linked recessive disease (long arm – band Xq28)
Highest prevalence in Jews (60-70%) and lowest in Japanese (0.1%), India
(2.6-3%)
G-6-PD deficiency provide partial protection against Malaria.
Variants of G-6-PD (WHO classification)
Glucose-6-phosphate dehydrogenase
Deficiency
Class Severity Enzyme Activity Hemolysis
Class I Severe
deficiency
<10% of normal Chronic hemolytic
Anemia
Class II Severe
deficiency
<10% of normal Intermittent
hemolysis
Class III Moderate
deficiency
10-60% of normal On exposure to
drugs
Class IV No deficiency 60-100% of normal No hemolysis
Class V - Increased (>twice
normal)
No hemolysis
35. G-6-PD B
Normal G-6-PD enzyme with half life of 62 days
G-6-PD A
Deficient enzyme with half life of 13 days
Enzyme stability is affected
Seen in Africans
G-6-PD Mediterranean
Half life of enzyme is less than 1 day; enzyme is deficient in RBC’s of all
ages.
Severe hemolysis
Indian Scenario
4 common variants
G6PD mediterranean
G6PD Kerala-Kalyan
G6PD Orissa
G6PD Chatram
Drug induced hemolysis is seen in patients with G6PD Kerala-Kalyan and
36. Pathophysiology of hemolysis in G-6-PD deficiency
Oxidant stress
Red ells deficient in G-6-PD
Depletion of NADPH and GSH
Oxidant stress in not hydrolysed
because of lack of GSH
Denatured globin, sulfhemoglobin is
formed
Sulf Hb attaches to red cell membrane
forming Heinz bodies
Removal of Heinz bodies in spleen
Extravascular hemolysis
Hemolytic anemia
Lysis of red cells in circulation
Intravascular hemolysis
Hemoglobinemia and
Hemoglobinuria
Hb absorbed by renal tubular cells
Hb hemosiderin inside tubular cells
Hemosiderinuria
37. Clinical presentation
Acute Hemolytic Anemia [self limiting], neonatal hyperbilirubinemia
Pallor, passage of dark urine
Abdominal pain, fever, chills, jaundice and severe backache
Favism, Acute renal failure
Multi organ failure
Diagnosis
Hematologic findings
Anemia with reticulocytosis
PBF - anisopoikilocytosis with polychromatophilia
Microspherocytes, bite cells, Heinz body, blister cells.
Urine – Hemoglobinuria, increased urobilinogen
Methemoglobin reduction test (MRT)
Ascorbate cyanide test
Fluorescent spot test
Cytochemical test
Dye decolorization test
Quantitative G-6-PD assay & DNA analysis by PCR
38.
39. This is the second common enzyme deficiency involving the glycolytic pathway
of red cell metabolism.
Autosomal recessive condition
Pyruvate kinase has 2 isoenzymes- PK-L (Liver) and PK-M (Muscles).
There is accumulation of G-3-P and 2,3-DPG and glucose
Clinical findings
Neonatal hyperbilirubinemia
Pallor, Gall stone, leg ulcers
Hematological findings-
moderate anemia with reticulocytosis.
Peripheral smear demostrates-
Presence of prickle cells
(red cells having sharp thorn like projections)
Quantitative assay and DNA analysis by PCR
Pyruvate Kinase Deficiency
40. Clinically – Mild splenomegaly with intermittent jaundice
Lab investigation –
Anemia with reticulocytosis
Marked Basophilic Stippling
Bone marrow – Erythroid Hyperplasia with late normoblasts
Raised S. Bilirubin
Pyrimidine 5’ – Nucleotidase deficiency
45. Clinical presentation
Anemia,
Progressive increase in pallor
Protuberant abdomen due to progressive hepatosplenomegaly
Frontal bossing due to thickening of cranial bone and overgrowth of
zygomatic bones
Mild jaundice
Cholelithiasis
Leg ulcer
Lab tests
PBF - Marked anisopoikilocytosis, MCHC
Tear drop cell and nRBC
Target cells
46.
47. Bone marrow
Hypercellular and demonstrates marked erythroid hyperplasia
Reversal of M:E ratio to 1:2 or 1:3
Normoblastic with mild degree of dyserythropoiesis
Hemosiderin laden macrophages
Acid elution test for HbF (Kleihauer test)
S. LDH – high
S. Haptoglobins – Low
Globin chain Synthesis (α:β – 2-30:1, normal 1:1)
Mutation Studies
Amplification Refractory Mutation System (ARMS) – PCR for point
mutations
PCR & multiplex PCR
Minisequencing
Reverse Dot Blot analysis
48. SICKLING SYNDROME
Sickle mutation is caused by substitution of valine in place of
glutamic acid in the 6th position (β6 glu-val) ofβ-chain
Mutation results in clinical presentation
Sickle cell anemia- HbS-HbS, Homozygous state
Sickle cell trait -HbA-HbS, heterozygous state
Sickle cell disease- Refer to all diseases with HbS in
combination with – normal (HbA), abnormal gene of b-
thalassemia, a-thalassemia, HbD, HbE, HbC, HbQ
Polymerization of deoxygenated HbS is the primary event in the
pathogenesis of the disease
49. Red cell containing
HbS
Passage through microcirculation of spleen
Low O2 tension
Deoxygenation of HbS and Sickling
Cells pass through circulation with good
O2 tension (Other organs) Desickling
Various cycles of sickling and desickling
Cell membrane affected and change in
membrane permeability
Irreversible sickling
Sickled RBCs Macrophage PhagocytosisIncreased mechanical
fragility
Extravascular hemolysisIntravascular hemolysis
50. Clinical features
Delay in puberty, growth and development
Recurrent leg ulcers
Avascular necrosis of femur head
Dactylitis ( Hand –Foot syndrome )
Pneumonia, meningitis, Osteomylitis
Jaundice and liver enlargement
Pigment gall stones
Acute abdominal pain ( infarcts of abdominal viscera)
Priapism
Acute chest syndrome
Sickle retinopathy- Salmon patches- intra retinal hemmorhages
51. Lab Investigation
Anemia- moderately severe anemia with Hb 5-10 gm
PBF demonstrates –
Normocytic normochromic to mildly hypochromic moderate to severe
degree of anisopoikliocytosis.
Sickle cells, target cells, ovalocytes, polychromtophila with nucleted
RBCs. Howell-jolly bodies also seen
TLC- Mildly elevated ; Platelets- Increased
Reticulocytosis- 3%-10%
52. Sickling tests- Presence of HbS demostrated by using reducing agent
like 2% sodium metabisulphite.
Sickling solubility test
Hb electrophoresis- HbS is a slow moving Hb as compared to HbA and
HbF. However, electrophoretic mobility of HbD/HbQ india is similar to
HbS, therefore sickling test is essential to differentiate.
HPLC- On HPLC, HbS has a retention time of 4.40 to 4.50 min, while
HbD punjab is is 4.50-4.15 min.